| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.03 | 0.6 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.026 | 0.6 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.6 |
| mRNA | PD-0332991 | FIMM | pan-cancer | AAC | 0.095 | 0.6 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.6 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |